Moneycontrol PRO
UPCOMING EVENT:Attend Traders Carnival Live. 3 days 12 sessions at Rs.1599/-, exclusive for Moneycontrol Pro subscribers. Register now!
you are here: HomeNewsBusiness

Glenmark Pharmaceuticals Q2 PAT seen up 18.4% YoY to Rs 269.5 cr: Prabhudas Lilladher

Net Sales are expected to decrease by 4.2 percent Y-o-Y (down 5.4 percent Q-o-Q) to Rs 2,786.7 crore, according to Prabhudas Lilladher.

October 06, 2021 / 06:00 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its second quarter (July-September’ 21) earnings estimates for the Pharma sector. The brokerage house expects Glenmark Pharmaceuticals to report net profit at Rs 269.5 crore up 18.4% year-on-year (down 12.1% quarter-on-quarter).


Net Sales are expected to decrease by 4.2 percent Y-o-Y (down 5.4 percent Q-o-Q) to Rs 2,786.7 crore, according to Prabhudas Lilladher.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 1.4 percent Y-o-Y (down 7.1 percent Q-o-Q) to Rs 515.5 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark